Abstract
Hilar cholangiocarcinoma, also known as Klatskin tumor or proximal extrahepatic cholangiocarcinoma, is an uncommon adenocarcinoma which arises from the epithelial cells of the biliary confluence of the right and left hepatic ducts. It accounts for nearly two thirds of cholangiocarcinoma and therefore is the most frequently encountered biliary tumor [1]. The estimated incidence of hilar cholangiocarcinoma is around 1:250,000 population. The cause for hilar cholangiocarcinoma is still unknown, although a variety of chronic inflammatory conditions of the biliary tree, such as sclerosing cholangitis, choledochal cysts, oriental cholangiohepatitis, and biliary parasitic disease, have been reported to increase the risk of bile duct cancers [2].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Aljiffry M, Walsh MJ, Molinari M. Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990–2009. World J Gastroenterol. 2009;15:4240–62.
Gatto M, Alvaro D. Cholangiocarcinoma: risk factors and clinical presentation. Eur Rev Med Pharmacol Sci. 2010;14:363–7.
Bismuth H, Castaing D, Traynor O. Resection or palliation: priority of surgery in the treatment of hilar cancer. World J Surg. 1988;12:39–47.
Tompkins RK, Thomas D, Wile A, et al. Prognostic factors in bile duct carcinoma: analysis of 96 cases. Ann Surg. 1981;194:447–57.
Ito F, Cho CS, Rikkers LF, Weber SM. Hilar cholangiocarcinoma: current management. Ann Surg. 2009;250:210–8.
Carriaga MT, Henson DE. Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer. 1995;75:171–90.
Otto G. Diagnostic and surgical approaches in hilar cholangiocarcinoma. Int J Colorectal Dis. 2007;22:101–8.
Cameron JL, Pitt HA, Zinner MJ, et al. Management of proximal cholangiocarcinomas by surgical resection and radiotherapy. Am J Surg. 1990;159:91–7; discussion 97–8.
Jarnagin WR, Fong Y, DeMatteo RP, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg. 2001;234:507–17; discussion 517–9.
Dinant S, Gerhards MF, Rauws EA, et al. Improved outcome of resection of hilar cholangiocarcinoma (Klatskin tumor). Ann Surg Oncol. 2006;13:872–80.
Petrowsky H, Hong JC. Current surgical management of hilar and intrahepatic cholangiocarcinoma: the role of resection and orthotopic liver transplantation. Transplant Proc. 2009;41:4023–35.
De Vreede I, Steers JL, Burch PA, et al. Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma. Liver Transpl. 2000;6:309–16.
Hidalgo E, Asthana S, Nishio H, et al. Surgery for hilar cholangiocarcinoma: the leeds experience. Eur J Surg Oncol. 2008;34:787–94.
Neuhaus P, Jonas S, Bechstein WO, et al. Extended resections for hilar cholangiocarcinoma. Ann Surg. 1999;230:808–18; discussion 819.
Song GW, Lee SG, Hwang S, et al. Does portal vein resection with hepatectomy improve survival in locally advanced hilar cholangiocarcinoma? Hepatogastroenterology. 2009;56:935–42.
Kawasaki S, Imamura H, Kobayashi A, et al. Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg. 2003;238:84–92.
Dinant S, Gerhards MF, Busch OR, et al. The importance of complete excision of the caudate lobe in resection of hilar cholangiocarcinoma. HPB (Oxford). 2005;7:263–7.
Neuhaus P, Jonas S, Settmacher U, et al. Surgical management of proximal bile duct cancer: extended right lobe resection increases resectability and radicality. Langenbecks Arch Surg. 2003;388:194–200.
Launois B, Reding R, Lebeau G, Buard JL. Surgery for hilar cholangiocarcinoma: French experience in a collective survey of 552 extrahepatic bile duct cancers. J Hepatobiliary Pancreat Surg. 2000;7:128–34.
Witzigmann H, Berr F, Ringel U, et al. Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection. Ann Surg. 2006;244:230–9.
Nishio H, Nagino M, Nimura Y. Surgical management of hilar cholangiocarcinoma: the Nagoya experience. HPB (Oxford). 2005;7:259–62.
Yokoyama Y, Nagino M, Nishio H, et al. Recent advances in the treatment of hilar cholangiocarcinoma: portal vein embolization. J Hepatobiliary Pancreat Surg. 2007;14:447–54.
Rea DJ, Munoz-Juarez M, Farnell MB, et al. Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients. Arch Surg. 2004;139:514–23; discussion 523–5.
Jonas S, Benckert C, Thelen A, et al. Radical surgery for hilar cholangiocarcinoma. Eur J Surg Oncol. 2008;34:263–71.
Hemming AW, Kim RD, Mekeel KL, et al. Portal vein resection for hilar cholangiocarcinoma. Am Surg. 2006;72:599–604; discussion 604–5.
Miyazaki M, Kato A, Ito H, et al. Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not? Surgery. 2007;141:581–8.
Abdel Wahab M, Fathy O, Elghwalby N, et al. Resectability and prognostic factors after resection of hilar cholangiocarcinoma. Hepatogastroenterology. 2006;53:5–10.
Giuliante F, Ardito F, Vellone M, et al. Liver resections for hilar cholangiocarcinoma. Eur Rev Med Pharmacol Sci. 2010;14:368–70.
Meyer CG, Penn I, James L. Liver transplantation for cholangioÂcarcinoma: results in 207 patients. Transplantation. 2000;69:1633–7.
Robles R, Figueras J, Turrion VS, et al. Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma. Ann Surg. 2004;239:265–71.
Shimoda M, Farmer DG, Colquhoun SD, et al. Liver transplantation for cholangiocellular carcinoma: analysis of a single-center experience and review of the literature. Liver Transpl. 2001;7:1023–33.
Rea DJ, Heimbach JK, Rosen CB, et al. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg. 2005;242:451–8; discussion 458–61.
Heimbach JK, Gores GJ, Haddock MG, et al. Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma. Transplantation. 2006;82:1703–7.
Wu Y, Johlin FC, Rayhill SC, et al. Long-term, tumor-free survival after radiotherapy combining hepatectomy-Whipple en bloc and orthotopic liver transplantation for early-stage hilar cholangiocarcinoma. Liver Transpl. 2008;14:279–86.
McBride CM, Wallace S. Cancer of the right lobe of the liver: a variety of operative procedures. Arch Surg. 1972;105:289–96.
Mehrabi A, Mood ZA, Roshanaei N, et al. Mesohepatectomy as an option for the treatment of central liver tumors. J Am Coll Surg. 2008;207:499–509.
Chouillard E, Cherqui D, Tayar C, et al. Anatomical bi- and trisegmentectomies as alternatives to extensive liver resections. Ann Surg. 2003;238:29–34.
Bismuth H, Corlette MB. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet. 1975;140:170–8.
Chen XP, Qiu FZ, Lau WY, et al. Mesohepatectomy for hepatocellular carcinoma: a study of 256 patients. Int J Colorectal Dis. 2008;23:543–6.
Chen XP, Lau WY, Huang ZY, et al. Extent of liver resection for hilar cholangiocarcinoma. Br J Surg. 2009;96:1167–75.
Sotiropoulos GC, Lang H, Molmenti EP, et al. Partial or complete mesohepatectomy combined with resection of the hilar bifurcation in cases of Klatskin tumors: a reasonable strategy? Am J Surg. 2009;198:297–8.
Miyazaki M, Ito H, Nakagawa K, et al. Parenchyma-preserving hepatectomy in the surgical treatment of hilar cholangiocarcinoma. J Am Coll Surg. 1999;189:575–83.
Kondo S, Hirano S, Ambo Y, et al. Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study. Ann Surg. 2004;240:95–101.
Capussotti L, Muratore A, Polastri R, et al. Liver resection for hilar cholangiocarcinoma: in-hospital mortality and longterm survival. J Am Coll Surg. 2002;195:641–7.
Seyama Y, Kubota K, Sano K, et al. Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg. 2003;238:73–83.
Ikeyama T, Nagino M, Oda K, et al. Surgical approach to bismuth Type I and II hilar cholangiocarcinomas: audit of 54 consecutive cases. Ann Surg. 2007;246:1052–7.
Jang JY, Kim SW, Park DJ, et al. Actual long-term outcome of extrahepatic bile duct cancer after surgical resection. Ann Surg. 2005;241:77–84.
Klempnauer J, Ridder GJ, Werner M, et al. What constitutes long-term survival after surgery for hilar cholangiocarcinoma? Cancer. 1997;79:26–34.
Hasegawa S, Ikai I, Fujii H, et al. Surgical resection of hilar cholangiocarcinoma: analysis of survival and postoperative complications. World J Surg. 2007;31:1256–63.
Pitt HA, Gomes AS, Lois JF, et al. Does preoperative percutaneous biliary drainage reduce operative risk or increase hospital cost? Ann Surg. 1985;201:545–53.
Maeno H, Ono T, Yamanoi A, et al. Our experiences in surgical treatment for hilar cholangiocarcinoma. Hepatogastroenterology. 2007;54:669–73.
Thelen A, Neuhaus P. Liver transplantation for hilar cholangiocarcinoma. J Hepatobiliary Pancreat Surg. 2007;14:469–75.
Pichlmayr R, Ringe B, Lauchart W, et al. Radical resection and liver grafting as the two main components of surgical strategy in the treatment of proximal bile duct cancer. World J Surg. 1988;12:68–77.
Miyazaki M, Ito H, Nakagawa K, et al. Segments I and IV resection as a new approach for hepatic hilar cholangiocarcinoma. Am J Surg. 1998;175:229–31.
White TT. Skeletization resection and central hepatic resection in the treatment of bile duct cancer. World J Surg. 1988;12:48–51.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht and People's Medical Publishing House
About this chapter
Cite this chapter
Huang, Z.Y., Chen, X.P. (2013). Central Lobectomy. In: Lau, W. (eds) Hilar Cholangiocarcinoma. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-6473-6_19
Download citation
DOI: https://doi.org/10.1007/978-94-007-6473-6_19
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-6472-9
Online ISBN: 978-94-007-6473-6
eBook Packages: MedicineMedicine (R0)